Background: This study aimed to explore the therapeutic effects of adipose-derived stem cells (ADSCs)-based microtissues (MTs) on erectile dysfunction (ED) in streptozotocin (STZ) induced diabetic rats. Methods: Fifty-six 8-week-old Sprague-Dawley rats received intraperitoneal injection of STZ (60 mg/kg) and eight weeks later, the determined diabetic rats randomly got intracavernous (IC) injection of phosphate buffer solution (PBS), ADSCs or MTs. Another eight normal rats equally received IC injection of PBS. MTs were generated with a hanging drop method and the injected cells were tracked in ADSCs and MTs injected rats. Four weeks after the treatments, intracavernous pressure (ICP), histopathological changes in corpus cavernosum (CC), and functional proteins were measured. Rat cytokine antibody array was used to detect ADSCs or MTs lysate. Results: MTs expressed vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and tumor necrosis factor-stimulated gene 6 (TSG-6). MTs injection had a higher retention than ADSCs injection and MTs treatment better improved ICP, neuronal nitric oxide synthase (nNOS) expression, smooth muscle and endothelial contents in diabetic rats, ameliorated local inflammation in CC. Conclusions: IC injection of MTs improves the erectile function and histopathological changes in streptozotocininduced diabetic rats and appears to be more promising than traditional ADSCs. The underlying mechanisms involve increased cell retention accompanied with neuroprotection and anti-inflammatory behaviors of the paracrine factors. Background: Although cancers are widely considered to be maintained by stem cells, the existence of stem cells in renal cell carcinoma (RCC) has seldom been reported, in part due to the lack of unique surface markers. We here identified cancer stem cell-like cells with side population (SP) phenotype in five human RCC cell lines. Methods: We here identified cancer stem cell-like cells with side population (SP) phenotype in five human RCC cell lines. Results: Flow cytometry analysis revealed that 769P, a human clear cell RCC cell line, contained the largest
AB240. Therapeutic effects of adipose-derived stem cellsbased micro-tissues on erectile dysfunction in streptozotocininduced diabetic rats Background: This study aimed to explore the therapeutic effects of adipose-derived stem cells (ADSCs)-based microtissues (MTs) on erectile dysfunction (ED) in streptozotocin (STZ) induced diabetic rats. Methods: Fifty-six 8-week-old Sprague-Dawley rats received intraperitoneal injection of STZ (60 mg/kg) and eight weeks later, the determined diabetic rats randomly got intracavernous (IC) injection of phosphate buffer solution (PBS), ADSCs or MTs. Another eight normal rats equally received IC injection of PBS. MTs were generated with a hanging drop method and the injected cells were tracked in ADSCs and MTs injected rats. Four weeks after the treatments, intracavernous pressure (ICP), histopathological changes in corpus cavernosum (CC), and functional proteins were measured. Rat cytokine antibody array was used to detect ADSCs or MTs lysate. Results: MTs expressed vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and tumor necrosis factor-stimulated gene 6 (TSG-6). MTs injection had a higher retention than ADSCs injection and MTs treatment better improved ICP, neuronal nitric oxide synthase (nNOS) expression, smooth muscle and endothelial contents in diabetic rats, ameliorated local inflammation in CC. Conclusions: IC injection of MTs improves the erectile function and histopathological changes in streptozotocininduced diabetic rats and appears to be more promising than traditional ADSCs. The underlying mechanisms involve increased cell retention accompanied with neuroprotection and anti-inflammatory behaviors of the paracrine factors. Background: Although cancers are widely considered to be maintained by stem cells, the existence of stem cells in renal cell carcinoma (RCC) has seldom been reported, in part due to the lack of unique surface markers. We here identified cancer stem cell-like cells with side population (SP) phenotype in five human RCC cell lines. AB242. An epigenetic biomarker combination of eomes, pcdh17, and pou4f2 detects bladder cancer accurately from methylation analyses of urine sediment DNA in Han Chinese
Song Wu
Shenzhen Lo Wu Affiliated Hospital, Guangdong 510310, China Background: To recognize a novel and optimized combination of epigenetic biomarkers capable of returning higher sensitivity and specificity synergistically in pathologically varied sample groups for urine sediment examination of bladder cancer (BlCa). Methods: Methylation levels of seven candidate biomarkers (EOMES, GDF15, NID2, PCDH17, POU4F2, TCF21, and ZNF154) in 58 urothelial cell carcinoma (UCC) patients, 20 infected urinary calculi (IUC) patients, 20 kidney cancer (KC) patients, and 30 healthy volunteers (HV) were quantified by qMSP using the sediment DNA of urine samples. Standard curves and receiver operating characteristic (ROC) curves were generated for each biomarker. The combining predictors of all the possible biomarker combinations were calculated through logistic regression model. Subsequently, the ROC curves of the three combinations that have yielded the best performing combining predictors were constructed. Results: From the samples provided, the top three biomarker combinations (C) returned high sensitivity and specificity of 91.38% and 94.29% from PCDH17 + POU4F2 (C1), 91.38% and 90.00% from PCDH17 + POU4F2 + NID2 (C2), and 93.10% and 92.86% from PCDH17 + POU4F2 + EOMES (C3) consequently. These combinations provide greater sensitivities and specificities than any examined single biomarkers, except for C2, which has a lower specificity compare to POU4F2 (92.86%).
Conclusions:
Compound biomarker panels were shown to be capable of detecting BlCa effectively by utilizing urine sediment DNA. Due to the performance of higher sensitivity and specificity when compared to single biomarker examinations in BlCa patients and the diverse control groups, these panels are particularly suitable for mass-scale routine BlCa screening. 
